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Ryanodine receptors (RyRs) are the calcium release channels of sarcoplasmic reticulum (SR) that provide the majority of cal-
cium ions (Ca2+) necessary to induce contraction of cardiac and skeletal muscle cells. In their intracellular environment, RyR 
channels are regulated by a variety of cytosolic and luminal factors so that their output signal (Ca2+) induces finely-graded cell 
contraction without igniting cellular processes that may lead to aberrant electrical activity (ventricular arrhythmias) or cellular 
remodeling. The importance of RyR dysfunction has been recently highlighted with the demonstration that point mutations in 
RYR2, the gene encoding for the cardiac isoform of the RyR (RyR2), are associated with catecholaminergic polymorphic ven-
tricular tachycardia (CPVT), an arrhythmogenic syndrome characterized by the development of adrenergically-mediated ven-
tricular tachycardia in individuals with an apparently normal heart. Here we summarize the state of the field in regards to the 
main arrhythmogenic mechanisms triggered by RyR2 channels harboring mutations linked to CPVT. Most CPVT mutations 
characterized to date endow RyR2 channels with a gain of function, resulting in hyperactive channels that release Ca2+ sponta-
neously, especially during diastole. The spontaneous Ca2+ release is extruded by the electrogenic Na+/Ca2+ exchanger, which 
depolarizes the external membrane (delayed afterdepolarization or DAD) and may trigger untimely action potentials. However, 
a rare set of CPVT mutations yield RyR2 channels that are intrinsically hypo-active and hypo-responsive to stimuli, and it is 
unclear whether these channels release Ca2+ spontaneously during diastole. We discuss novel cellular mechanisms that appear 
more suitable to explain ventricular arrhythmias due to RyR2 loss-of-function mutations. 
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Ca2+ is an indispensable factor for the generation of the 
contractile force that gives rise to the heartbeat. In ventricu-
lar cardiomyocytes, depolarization of the sarcolemma and 
its invaginations, the T-tubules, induces the opening of 
voltage-dependent L-type Ca2+ channels (also known as 
dihydropyridine receptors, DHPRs), which permit the entry 
of a small amount of Ca2+ (ICa) into the cell. In adult cardi-
omyocytes, ICa is insufficient to elicit full contractions, but 
is capable of triggering massive release of Ca2+ from the 
sarcoplasmic reticulum (SR), which then bathes the con-
tractile filaments, binds to Ca2+-binding proteins, and finally 
induces contraction [1]. This amplification process, known 
as Ca2+-induced Ca2+ release (CICR) [2], is mediated by 
Ca2+ activation of Ca2+ release channels (also known as 
ryanodine receptors, RyRs), which represent the major, if 
not the only, pathway for Ca2+ release from the SR [3]. 
CICR amplifies the incoming Ca2+ signal ~420 fold (de-
pending on the animal species) and is therefore the major 
component of the intracellular Ca2+ transient that induces 
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contraction. The efficiency of communication between 
T-tubules and the SR, or specifically, the “fidelity” of 
DHPR→RyR signaling, determines to a great extent the 
magnitude of Ca2+ release from the SR, and thus the force 
of contraction [4]. 
ICa is a critical component of the plateau phase of the ac-
tion potential (AP) and it has been experimentally estab-
lished that maneuvers that alter the AP waveform may di-
rectly or indirectly affect SR Ca release [5]. Thus, APs con-
trol the magnitude and time course of Ca2+ release, and the 
flow of information AP→Ca2+ release is unquestionable. 
However, there is also an emergent role for the retroactive 
feedback that SR Ca2+ release exerts on ICa (Ca
2+ release→
AP). L-type Ca2+ channels open in response to depolariza-
tion and then enter into an absorbing state of inactivation, 
which comprises a fast, Ca2+-dependent component, and a 
slow, voltage-dependent component [6]. Hence, in the ab-
sence of Ca2+ release, Ca2+-dependent inactivation of ICa is 
slowed, which prolongs the duration of the AP and favors 
the generation of arrhythmic substrates [7]. Also, Ca2+ re-
leased from the SR is normally recaptured by the SR Ca2+ 
ATPase (SERCA2a), but it may also be rapidly extruded by 
the electrogenic Na+/Ca2+ exchanger of the sarcolemma, 
generating in turn an inward current that may bring mem-
brane potential to threshold and generate an untimely AP. 
Therefore, there is mutual entrainment of APs and Ca2+ re-
lease, and it thus follows that RyR dysfunction, by altering 
Ca2+ release, prompts cardiomyocytes to generate arrhyth-
mic behavior. In this review we discuss conventional and 
novel pathogenic mechanisms by which RyR dysfunction 
may cause cardiac arrhythmias. 
1  Catecholaminergic polymorphic ventricular 
tachycardia 
1.1  Brief clinical description 
Catecholaminergic polymorphic ventricular tachycardia 
(CPVT) is a genetic and highly malignant arrhythmogenic 
disease that may lead to sudden death in children and young 
adults [8]. To date, more than ~160 mutations in RYR2, the 
gene encoding for the cardiac isoform of the RyR (RyR2), 
are linked to CPVT1, the dominant form of the syndrome, 
but it is clear that CPVT is an arrhythmogenic syndrome 
caused by intracellular Ca2+ mishandling, as mutations in 
cardiac isoform of the calsequestrin (CSQ2) [9] and triadin 
[10], two SR luminal proteins that regulate Ca2+ release 
through RyR2 channels, cause a recessive form of the dis-
ease (CPVT2 and CPVT3, respectively). Very recently, 
mutations in calmodulin, which directly binds to the cyto-
solic portion of RyR2, were also linked to this syndrome 
[11]. When CPVT was first described by Leenhardt et al. 
[12] in 1995, it was considered a rare syndrome, but molec-
ular screenings for RYR2 and CSQ2 mutations in children 
with positive exercise stress testing and absence of cardiac 
structural defects have improved diagnosis and prognosis of 
the disease. As the name implies, CPVT is triggered by the 
surge of catecholamines that usually occurs during physical 
exercise or emotional stress in otherwise electrophysiologi-
cally normal individuals. Although electrocardiography 
(ECG) abnormalities are diverse (hence the term “poly-
morphic”), many patients present bidirectional ventricular 
tachycardia (BiVT), a 180° beat-to-beat rotation of the axis 
of the QRS complexes that is considered a cardinal sign of 
the disease [13]. Remarkably, BiVT is also the hallmark of 
ventricular tachycardias in patients with digitalis intoxica-
tion [14], which arise from Na+-induced Ca2+ overload, 
clearly linking both syndromes to common intracellular 
Ca2+ mishandling mechanisms.  
1.2  Conventional arrhythmogenic mechanism for 
CPVT 
The vast majority of the RyR2-linked CPVT mutations 
studied to date have been found to endow RyR2 channels 
with a gain of function, that is, the mutations generate hy-
per-active or hyper-reactive RyR2 channels, and this finding 
restricts the cellular basis of the cardiac arrhythmias to a 
well-defined cascade of events, succinctly described as fol-
lows: during sympathetic stimulation, enhanced ICa plus 
enhanced SR Ca2+ uptake promoted by activation of PKA 
and likely CaMKII, lead to intracellular Ca2+ overload. In 
normal ventricular myocytes, this excess of intracellular 
[Ca2+] promotes stronger contractions (increased inotro-
pism), a characteristic benefit of the fight-or-flight response. 
But in the setting of CPVT, this Ca2+ overload constitutes a 
powerful incentive for a group of mutation-deranged hy-
peractive RyR2 channels to release Ca2+ on their own, that 
is, to spew Ca2+ in the absence of ICa stimulation. When 
spontaneous Ca2+ release occurs during diastole, Ca2+ is 
rapidly extruded by the Na+/Ca2+ exchanger, as mentioned 
above, generating an inward current and gradually depolar-
izing the membrane potential, a phenomenon termed “de-
layed afterdepolarization”, or DAD (Figure 1, right side). If 
the amount of Ca2+ release is of sufficient mass to bring a 
DAD to threshold, it generates a full AP, which is the cellu-
lar basis for the triggered activity that disseminates to con-
tiguous cells, forming discrete ectopic foci. In this scheme, 
therefore, spontaneous Ca2+ release via hyperactive RyR2 
channels entrains sarcolemmal currents by means of the 
Na+/Ca2+ exchanger at a well-defined period of the AP 
(phase 4 or diastole). Note also that, although hyperactive, 
mutant RyR2 channels are not portrayed malfunctioning 
during the systolic phase of Ca2+ release. Most studies that 
used mice as models of CPVT remark the excessive dias-
tolic Ca2+ leak [1517], but do not observe significant alter-
ations in their systolic [Ca2+]i transient.
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Figure 1  Arrhyhmogenic mechanisms in ventricular myocytes harboring RyR2 mutations linked to CPVT. Left side, CPVT mutations that render RyR2 
channels hypo-active or hypo-responsive to stimuli. Depolarization of T-tubules open L-type Ca2+ channels (DHPRs, or Cav1.2), which induce the opening of 
RyR2 channels in the SR. Ca2+ release from the SR then contributes to inactivate the L-type Ca2+ channel current (ICa). If Ca
2+ release is reduced, then there is 
altered inactivation of ICa, prolongation of the action potential, and generation of early afterdepolarizations (EADs). Right side, The vast majority of CPVT 
mutations endow RyR2 channels with a gain-of-function. Stimulation of β1-adrenergic receptors by epinephrine activates PKA, which enhances Ca2+ entry 
and accelerates SR Ca2+ re-uptake by phosphorylating L-type Ca2+ channels and phospholamban, respectively. The overall effect of sympathetic stimulation 
is an intracellular Ca2+ overload that increases the strength of contractions. In the process, when SR Ca2+ content is elevated, RyR2 channels hyper-sensitized 
by the CPVT mutations release Ca2+ spontaneously, usually in diastole, generating a depolarizing current (delayed afterdepolarization or DAD) as the re-
leased Ca2+ is extruded by the electrogenic Na+/Ca2+ exchanger. If Ca2+ released is of sufficient mass, it may generate a full action potential, which is the 
basis for triggered activity. See text for more details. 
1.3  Molecular mechanisms that may underlie excessive 
Ca2+ release  
Several molecular mechanisms have been advanced to ex-
plain why RyR2 channels bearing CPVT mutations are 
prone to discharge excessive amounts of Ca2+ during dias-
tole and cause DADs. A reduction in the threshold for acti-
vation of mutant RyR2 channels by luminal Ca2+ is one of 
the most prominent mechanisms [18,19]. In this scheme, 
normal RyR2 channels do not release Ca2+ on their own 
because the luminal [Ca2+] that is reached during basal con-
ditions and even during sympathetic stimulation is below 
their threshold for activation. In contrast, a CPVT mutation 
presumably lowers the RyR2 channel’s threshold for lu-
minal Ca2+ activation, and although mutant channels remain 
“silent” under basal conditions, they “ignite” during the 
normal sympathetic Ca2+ overload. This scheme has been 
demonstrated in a great number of, but not all, RyR2 muta-
tions linked to CPVT [15,16], and although intelligible at its 
core, is likely accompanied by other mechanisms. Defective 
RyR2 inter-domain interactions was originally proposed by 
Ikemoto’s group to explain the effect of synthetic peptides 
with amino acid sequence identical to specific segments of 
the RyR to increase the activity of the same channels [20]. 
In this scheme, normal RyR2 channels are believed to be 
leak-resistant by interdomain interactions that “zip” various 
segments of the RyR2 protein and stabilize the channel in a 
closed state. Consequently, mutations occurring within the 
interactive domains may trigger CPVT episodes because 
they tend to ‘‘unzip’’ those interactions and thus destabilize 
the channel, favoring Ca2+ leak [21]. This hypothesis is 
supported by the fact that most CPVT mutations fall within 
three well defined segments (or “hot spots”) of the RyR2 
linear sequence, namely, residues 77466 (N-terminal seg-
ment or domain I), residues 22462534 (domain II), and 
residues 37784959 (C-terminal segment or domain III). It 
is therefore conceivable that these segments interact with 
each other to stabilize the channel in the closed state and, in 
fact, there is already some structural evidence that domains 
I and II do so [22]. Mutations in these regions would thus 
destabilize the close state of the channel and allow exces-
sive Ca2+ leak. The hierarchy of these “hot spots” in the 
control of the channel’s stability is also demonstrated by the 
fact that equivalent mutations in RYR1, the gene encoding 
for the skeletal isoform of the RyR (RyR1), give rise to Ma-
lignant Hyperthermia and Central Core Disease, two devas-
tating diseases of skeletal muscle whose primary pathogenic 
mechanism is also excessive Ca2+ leak from the SR [23]. 
Dissociation of FKBP12.6 from RyR2 has also been postu-
lated as the central mechanism that triggers CPVT [2426]. 
Marks and colleagues have found that RyR2 channels har-
boring mutations that give rise to CPVT tend to dissociate 
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FKBP12.6 more readily than wild-type channels. Since 
FKBP12.6 is presumed to stabilize RyR2 channels in their 
closed state (a contentious issue by itself [27,28]), a 
FKBP12.6-free RyR2 channel would dwell in the open state 
for longer times, generating the excessive Ca2+ leak which 
is at the center of the pathogenic mechanisms of CPVT 
mentioned above. This hypothesis is attractive because 
CPVT episodes occur by definition during adrenergic stim-
ulation, and normal phosphorylation of RyR2 channels by 
PKA (the main kinase linking β-adrenergic stimulation to 
cellular effects) is presumed to dissociate FKBP12.6 from 
RyR2 [29]. Thus, it would only be required that this reac-
tion was more pronounced in the mutant RyR2 channels to 
generate excessive Ca2+ leak. However, several key aspects 
of this hypothesis have not been confirmed by others, since 
others have found no evidence of FKBP12.6 dissociation in 
CPVT mutation-harboring RyR2 [30]. Finally, it is worth 
considering that there is no a priori reason to rule out multi-
ple mechanisms affected by a single mutation and working 
in unison to destabilize the channel and generate spontane-
ous Ca2+ release. This heterogeneity of RyR2 dysfunction 
caused by CPVT mutations is actually expected if we con-
sider that most CPVT mutations fall in domains of the 
RyR2 sequence that control several aspects of channel func-
tion, including regions involved in Ca2+ sensing, excita-
tion-contraction coupling, phosphorylation, redox sensing, 
and others (reviewed in [30]). Also, some amino acid resi-
dues appear central to maintain the global integrity of the 
channel, and mutations in these critical residues alter multi-
ple aspects of channel function. Loaiza et al. [31] showed at 
least three different mechanisms of channel dysfunction in 
RyR2-V2475F channels. 
1.4  Different arrhythmogenic mechanisms for RyR2 
loss-of-function mutations linked to CPVT? 
Although spontaneous Ca2+ release, especially during dias-
tole, is the most accepted cellular mechanism underlying 
ventricular tachyarrhythmias in CPVT, it appears insuffi-
cient to explain the same tachyarrhythmias in patients suf-
fering RyR2 loss-of-function mutations. If a mutation ren-
ders a RyR2 channel hypo-active or hypo-responsive, is it 
still possible that this channel “ignites” eagerly during a 
normal, sympathetically-induced Ca2+ overload? If the 
hallmark of a hyperactive RyR2 channel (gain-of-function 
mutation) is its trigger-readiness and promptitude to release 
Ca2+ on its own, would a hypo-active channel show exact 
opposite attributes, that is, resilience to release Ca2+ spon-
taneously, if at all? The question is relevant because, scan-
ning the phenotype of several RyR2 channels harboring 
CPVT mutations, Chen and co-workers [32] found that at 
least one of them, RyR2-A4860G, exhibited a pronounced 
loss-of-function characterized by a markedly depressed re-
sponse to luminal Ca2+ and extremely low open probability 
in the presence of full agonists such as cytosolic Ca2+ and 
caffeine. In a cohort of CPVT patients, the RyR2-A4860G 
mutation had been detected in a 6-year-old girl who pre-
sented idiopathic ventricular fibrillation, was treated with 
β-blockers, and had an implantable cardioverter [33].   
The experiments of Chen and colleagues were crucial to 
expose the novel loss of function attribute of RyR2-A4860G 
but could not reveal the mechanism by which the mutation 
causes arrhythmias because they were conducted using ho-
mogeneous recombinant mutant protein (equivalent to a 
homozygous mutation, whereas the patient was heterozy-
gous for the mutation) and in heterologous expression sys-
tems (HEK293 cells), which are poor substitutes for cardiac 
myocytes [32]. We generated a mouse line harboring the 
RyR2-A4860G mutation to investigate whether this animal 
recapitulated the cardinal signs of the disease and could 
yield information on its arrhythmogenic mechanisms [34]. 
Under basal conditions, mice heterozygous for the 
RyR2-A4860G mutation (RyR2-A4860G+/) exhibited 
bradycardia but showed no major cardiac structural abnor-
malities. No homozygotes were detected at birth, indicating 
that the RyR2-A4860G mutation is phenotypically too 
strong to be harbored in the two alleles. Anesthetized 
RyR2-A4860G+/ mice injected with an arrhythmogenic 
cocktail (120 mg kg1 caffeine and 2 mg kg1 epinephrine) 
displayed ECG alterations consisting with QRS alternans, 
premature ventricular complexes and BiVTs, whereas ECGs 
of WT mice remained normal under the same conditions. 
Simultaneous recording of action potentials and intracellular 
calcium transients ([Ca2+]i) in isoproterenol (300 nmol 
L1)-stimulated RyR2-A4860G+/ ventricular myocytes 
showed prolonged action potentials and interspaced bursts 
of altered Ca2+ release consisting of a normal peak followed 
by a second, prolonged phase of release during the systolic 
phase. Remarkably, early afterdepolarizations (EADs) were 
observed only during the prolonged phase of release, and 
were abolished by either the NCX inhibitor CB-DMB ex-
tracellularly applied or the Ca2+ chelator EGTA (10 mmol 
L1, intracellular). The RyR2-A4860G loss-of-function mu-
tation thus reveals novel mechanisms of arrhythmogenesis 
in CPVT: first, mutant RyR2 channels decrease the peak of 
Ca2+ release during systole and thus impair L-type Ca2+ 
channel inactivation (faulty retroactive Ca2+ release→AP 
feedback), both of which gradually overload the SR. The 
resultant SR overload then causes bursts of prolonged Ca2+ 
release, which activate electrogenic Na+/Ca2+ exchange ac-
tivity during the plateau and descending phases of the AP, 
triggering EADs (Figure 1, left side). These novel pathways 
by which RyR2 channels engage membrane currents may 
also produce life-threatening arrhythmias.  
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